Home LiteratureArticle Details
PMID: 9923855 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia.

Journal of the National Cancer Institute ·Vol. 91 ·No. 2 ·1999-01-20 ·Pages 143-51

Thrash-Bingham CA, Tartof KD

Abstract

Nonpapillary renal carcinoma is the predominant form of human kidney cancer and represents a distinct disease entity, morphologically and molecularly, from papillary renal carcinoma. We have discovered a natural antisense transcript that is complementary to the 3' untranslated region of hypoxia inducible factor alpha (HIF1alpha) messenger RNA (mRNA) and is strikingly overexpressed specifically in nonpapillary kidney cancer. HIF1alpha encodes a protein that is known to have two important functions: 1) to act as a transcription factor for hypoxia inducible genes and 2) to stabilize p53 protein during hypoxia. Because of the importance of HIF1alpha, we have characterized this natural antisense transcript, which we have named "aHIF." Differential display, reverse transcription-polymerase chain reaction, ribonuclease protection, and DNA-sequencing methods were used in our analysis. We show the following: 1) aHIF is a natural antisense transcript derived from HIF1alpha gene sequences encoding the 3' untranslated region of HIF1alpha mRNA; 2) aHIF is specifically overexpressed in all nonpapillary clear-cell renal carcinomas examined, but not in the papillary renal carcinomas examined; 3) aHIF is overexpressed in an established nonpapillary renal carcinoma cell line under both normoxic (i.e., normal aerobic) and hypoxic conditions; and 4) although aHIF is not further induced by hypoxia in nonpapillary disease, it can be induced in lymphocytes where there is a concomitant decrease in HIF1alpha mRNA. To our knowledge, this is the first case of overexpression of a natural antisense transcript exclusively associated with a specific human malignant disease.

MeSH Terms
Adenocarcinoma, Clear Cell/metabolism Base Sequence Carcinoma, Renal Cell/metabolism Cloning, Molecular DNA, Complementary DNA-Binding Proteins/biosynthesis Humans Hypoxia/metabolism Hypoxia-Inducible Factor 1 Hypoxia-Inducible Factor 1, alpha Subunit Kidney Neoplasms/metabolism Molecular Sequence Data Nuclear Proteins/biosynthesis Oligonucleotides, Antisense/metabolism RNA, Messenger/metabolism RNA, Neoplasm/metabolism Reverse Transcriptase Polymerase Chain Reaction Transcription Factors/biosynthesis Up-Regulation
Chemicals
DNA, Complementary DNA-Binding Proteins HIF1A protein, human Hypoxia-Inducible Factor 1 Hypoxia-Inducible Factor 1, alpha Subunit Nuclear Proteins Oligonucleotides, Antisense RNA, Messenger RNA, Neoplasm Transcription Factors
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Thrash-Bingham C A
Fox Chase Cancer Center, Philadelphia, PA, USA.
Tartof K D
Article Info
Journal
Journal of the National Cancer Institute
Abbr.
J Natl Cancer Inst
ISSN
0027-8874
Published
1999-01-20
Pages
143-51
Language
English
Region
United States
NLM ID
7503089
Subset
IM
Grants
NCI NIH HHS · CA06927 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com